It wasn't so long ago when diabetes was one of the hot sectors of med-tech where many companies felt they had to have a presence, no matter what the cost. And while it is true that the incidence of diabetes continues to increase at worrisome rates in many countries, the diabetes market is no longer a “build it (or buy it), and the growth will come” type of proposition. It may not be quite true that diabetes as become a “winner takes all” sort of market, it is definitely a market where data, pricing, and marketing muscle make a big difference.
Please click below to continue:
http://www.massdevice.com/blogs/massdevice/strange-case-diabetes-market
0 comments:
Post a Comment
Click to see the code!
To insert emoticon you must added at least one space before the code.